Collectively, these results demonstrate that RaST recruited a higher number of CD11b+ and CD11c+ tumor-infiltrating immune cells than the marginal CD8b+ cells (Fig. 5h), indicating the dominance of innate than adaptive immune response. The gene discussed is CD8B; the disease is neoplasm.